Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oogenesis02:07

Oogenesis

63.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma orexin-A levels in women with postpartum depression: a prospective controlled study.

Revista da Associacao Medica Brasileira (1992)·2026
Same author

Predictive Value of Abdominal Subcutaneous Fat Thickness for Dinoprostone-Induced Labor Success in Obese Pregnant Women: A Prospective Observational Study.

Journal of clinical medicine·2026
Same author

Long-Term Durability and Dynamics of Anti-S-RBD IgG Response in Healthcare Workers: A Comparative Analysis of Homologous and Heterologous SARS-CoV-2 Vaccination Schedules in a 1-Year Serial Cross-Sectional Study.

Medical science monitor : international medical journal of experimental and clinical research·2026
Same author

An Investigation of the Effects of Melatonin and Vitamin D on the Ovaries of a Rat Model of Premature Ovarian Failure Induced by Cyclophosphamide.

International journal of molecular sciences·2025
Same author

First evaluation of fibroblast growth factor 21 levels in patients diagnosed with glycogen storage diseases with liver involvement.

Journal of pediatric endocrinology & metabolism : JPEM·2025
Same author

Effects of liraglutide on the testis of rats with experimental diabetes and ischemia-reperfusion injury.

Biotechnic & histochemistry : official publication of the Biological Stain Commission·2025

Related Experiment Video

Updated: Jul 19, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.7K

Does resveratrol reduce cisplatin-induced ovarian damage?

Baris Ciplak1, Eyup Gokhan Turmus2, Ozlem Kara3

  • 1Malatya Training and Research Hospital, Clinic of Obstetrics and Gynecology - Malatya, Turkey.

Revista Da Associacao Medica Brasileira (1992)
|August 16, 2023
PubMed
Summary

Resveratrol protects against cisplatin-induced ovarian damage by reducing injury and improving key biochemical markers in experimental models. This finding highlights its potential therapeutic role in mitigating chemotherapy-related reproductive toxicity.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K
Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
11:50

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

Published on: September 10, 2014

13.5K

Related Experiment Videos

Last Updated: Jul 19, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.7K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K
Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
11:50

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

Published on: September 10, 2014

13.5K

Area of Science:

  • Reproductive toxicology
  • Pharmacology
  • Biochemistry

Background:

  • Cisplatin is a widely used chemotherapy agent with known ovarian toxicity.
  • Ovarian damage can lead to infertility and other reproductive complications.
  • Resveratrol, a natural polyphenol, has demonstrated antioxidant and anti-inflammatory properties.

Purpose of the Study:

  • To evaluate the protective effects of resveratrol against cisplatin-induced ovarian damage.
  • To assess the impact of resveratrol on biochemical and histopathological parameters of ovarian injury.
  • To investigate resveratrol's influence on oxidative stress markers in the ovary.

Main Methods:

  • Female Wistar-Albino rats were divided into three groups: control (NaCl), cisplatin-induced damage, and cisplatin plus resveratrol.
  • Ovarian tissues were analyzed using histopathological examination and scoring.
  • Biochemical assays were performed to measure malondialdehyde (MDA), catalase (CAT), and superoxide dismutase (SOD) levels.
  • Immunohistochemical staining for c-kit expression was used to assess ovarian function.

Main Results:

  • Cisplatin administration significantly increased the histopathological findings score, indicating ovarian damage.
  • Resveratrol treatment (Group 3) showed significantly higher superoxide dismutase and catalase levels compared to the cisplatin-only group (Group 2).
  • Malondialdehyde levels were significantly elevated in the cisplatin-induced damage group (Group 2) compared to the resveratrol-treated group (Group 3).

Conclusions:

  • Resveratrol demonstrated a protective effect against cisplatin-induced ovarian injury in experimental models.
  • Resveratrol administration improved key biochemical parameters, including antioxidant enzyme activity and lipid peroxidation markers.
  • These findings suggest resveratrol's potential as a therapeutic agent to mitigate chemotherapy-induced ovarian toxicity.